More than 96 million American adults—more than one in three of us—have prediabetes: blood sugar levels that are lower than…
Are pharmaceuticals the answer to America’s diabetes problem?
Popular acid reflux drugs, called proton pump inhibitors, may increase risk for type 2 diabetes, especially with regular use for longer than two years.
For decades, people with diabetes have relied on finger sticks to track their blood sugar. Continuous glucose monitoring is worth considering. Read on…
If you want to avoid diabetes, there’s more to it than choosing foods low in sugar and fat. Here’s how to attack the root cause…
Older diabetics may have dangerously low blood sugar daily, says a recent study. Those with type 1 diabetes or anyone on insulin are at greatest risk.
It’s not just excess weight and lack of exercise that raise your diabetes risk. Research now shows negativity also plays a role for certain women…
With no generic available, the cost of this lifesaving medication is skyrocketing. Here’s how to spend less without jeopardizing your health.
If you do this right, you can live up to 14 years longer by putting your heart attack and stroke risks on par with people without diabetes.
Managing diabetes takes an emotional toll. How you handle it can make a life-or-death difference
Drugs that stimulate insulin may cause other effects that snowball into a rare but deadly cancer.
If you have diabetes, it's normal to have mild low blood sugar—hypoglycemia—sometimes. But severe hypoglycemia is dangerous. Here's how to prevent it.
Three popular diabetes drugs—the SGLT-2i drugs Farxiga, Invokana and Jardiance—may double risk for foot amputation. What’s your real risk?
Is it a crazy idea or the perfect preventive step? A monitoring system used by people with diabetes can reveal early warning signs in “healthy” people.
Blood-sugar lowering SGLT-2 inhibitor drugs—such as Farxiga, Invokana and Jardiance—treat diabetes and protect your heart at the same time.
Copyright © 2023 Bottom Line Inc. 535 Connecticut Avenue, Norwalk, CT 06854
Bottom Line, Inc. publishes the opinions of expert authorities in many fields These opinions are for educational and illustrative purposes only and should not be considered as either individual advice or as a substitute for legal, accounting, investment, medical and other professional services intended to suit your specific personal needs. Always consult a competent professional for answers specific to your questions and circumstances. Our content is further subject to our Terms and Conditions